We are excited to introduce SynbiTECH 2023, the must-attend event of the year for professionals in the fields of synthetic biology (engineering biology), biotech, business, engineering, and technology.
Date: 5th – 6th December
Location: IET London: Savoy Place WC2R 0BL
Theme: Building a multibillion-dollar synthetic biology industry with positive impact
SynbiTECH 2023 is produced by two distinguished global leaders in synthetic biology: Professors Richard Kitney and Paul Freemont, who serve as Co-directors of SynbiCITE at Imperial College London.
Why SynbiTECH 2023 is a Can’t-Miss Event:
SynBio Insights: Explore the dynamic synergy between artificial intelligence and synthetic biology, how SynBio can tackle the challenges of climate change and how investors view the sector. Experience thought-provoking discussions, unravelling the immense potential AI holds in shaping the future of SynBio.
Startup Showcases: Witness cutting-edge startups unveiling revolutionary concepts. Be the first to discover the next big thing in SynBio and mingle with entrepreneurs who are reshaping our future.
Engage with Visionaries: Join 400+ passionate SynBio enthusiasts, startups, investors, and academics. Network with the brightest minds in the UK’s SynBio community, sharing groundbreaking ideas and forging collaborations that could change the world.
Innovate & Inspire: Immerse yourself in two days of passionate debates and insightful presentations. Learn from trailblazers, gain unparalleled insights, and ignite your imagination with the limitless possibilities that lie at the intersection of AI and Synthetic Biology.
Line-up so far:
Sir Brian Hoskins – Grantham Institute
Dr Mary E. Maxon – Schmidt BioFutures
Dr Piers Millett (Chair) – International Biosecurity and Biosafety
Professor Petra Oyston – Synthetic Biology Lead at Defence Science and
Hannah Kinsey – Tech Strategy and Security at Department for Science,
Dr Cassidy Nelson – Head of Biosecurity Policy at Centre of Long-Term
Dr Orr Yarkoni – Founder and CEO of Colorifix
Dr Gustaf Hemberg – Founder and CEO of Scindo
Dr Matthew Duchars – CEO of Chain Biotechnology
Professor Anne Osbourn, OBE FRS NAS – Group Leader at the John Innes Center / HotHouse Therapeutics
Dr James Field – Founder and CEO of LabGenius
Fiona Mischel (Chair) – Director of International Outreach at Synbiobeta
Professor Anne Osbourn, OBE FRS NAS – Group Leader at the John Innes Center / HotHouse Therapeutics
Professor Susan Rosser – Director of the Edinburgh Mammalian Synthetic Biology Research Centre
Dr Izzy Webb – Head of Engineering Biology and Strategy at the Department for Science, Innovation and Technology
Dr Leonard Wossnig – Chief Technology Officer at LabGenius
Dr Per Greisen – VP of Computational Drug Design at BioMap
Dr Nicole Wheeler – University of Birmingham
Dr Rodrigo Ledesma Amaro – Cofounder of Ublii
Dr Ben Reeve – Cofounder of Modern Synthesis
Dr Miroslav Gasparek – CEO and Cofounder of Sensible Bio
Dr Matthew Cummings – Cofounder of CC Bio
Professor Natalio Krasnogor – Founder and CTO of Gitlife
Dr James McDonald – CTO of Solena Materials
Professor Dame Angela Mclean – Government Chief Scientific Advisor
Don’t miss your chance to be a part of this transformative event. Limited tickets are available, and they’re selling fast.